MY203278A - Process of making calcium alpha-ketoglutarate - Google Patents

Process of making calcium alpha-ketoglutarate

Info

Publication number
MY203278A
MY203278A MYPI2021001576A MYPI2021001576A MY203278A MY 203278 A MY203278 A MY 203278A MY PI2021001576 A MYPI2021001576 A MY PI2021001576A MY PI2021001576 A MYPI2021001576 A MY PI2021001576A MY 203278 A MY203278 A MY 203278A
Authority
MY
Malaysia
Prior art keywords
ketoglutarate
making calcium
calcium alpha
alpha
making
Prior art date
Application number
MYPI2021001576A
Other languages
English (en)
Inventor
David Eugene Pereira
Keshav Deo
Original Assignee
Ponce De Leon Health Designated Activity Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ponce De Leon Health Designated Activity Company filed Critical Ponce De Leon Health Designated Activity Company
Publication of MY203278A publication Critical patent/MY203278A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/41—Preparation of salts of carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/41—Preparation of salts of carboxylic acids
    • C07C51/412—Preparation of salts of carboxylic acids by conversion of the acids, their salts, esters or anhydrides with the same carboxylic acid part
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/41—Preparation of salts of carboxylic acids
    • C07C51/418—Preparation of metal complexes containing carboxylic acid moieties
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/347—Saturated compounds containing more than one carboxyl group containing keto groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fodder In General (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
MYPI2021001576A 2018-09-25 2019-09-23 Process of making calcium alpha-ketoglutarate MY203278A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862736320P 2018-09-25 2018-09-25
PCT/US2019/052498 WO2020068705A1 (en) 2018-09-25 2019-09-23 Process of making calcium alpha-ketoglutarate

Publications (1)

Publication Number Publication Date
MY203278A true MY203278A (en) 2024-06-21

Family

ID=69952136

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2021001576A MY203278A (en) 2018-09-25 2019-09-23 Process of making calcium alpha-ketoglutarate

Country Status (18)

Country Link
US (1) US11802103B2 (cg-RX-API-DMAC7.html)
EP (1) EP3856166A4 (cg-RX-API-DMAC7.html)
JP (1) JP7499259B2 (cg-RX-API-DMAC7.html)
KR (1) KR102833111B1 (cg-RX-API-DMAC7.html)
CN (1) CN112955139B (cg-RX-API-DMAC7.html)
AU (1) AU2019350699B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021005668A2 (cg-RX-API-DMAC7.html)
CA (1) CA3112205A1 (cg-RX-API-DMAC7.html)
CL (1) CL2021000728A1 (cg-RX-API-DMAC7.html)
CO (1) CO2021004529A2 (cg-RX-API-DMAC7.html)
IL (1) IL281761B2 (cg-RX-API-DMAC7.html)
MX (1) MX2021003482A (cg-RX-API-DMAC7.html)
MY (1) MY203278A (cg-RX-API-DMAC7.html)
PE (1) PE20211816A1 (cg-RX-API-DMAC7.html)
PH (1) PH12021550403A1 (cg-RX-API-DMAC7.html)
SG (1) SG11202102204PA (cg-RX-API-DMAC7.html)
TW (1) TWI863930B (cg-RX-API-DMAC7.html)
WO (1) WO2020068705A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112955139B (zh) 2018-09-25 2025-04-18 庞塞迪利昂健康特定活动公司 用于制备α-酮戊二酸钙的方法
CN112941116B (zh) * 2021-01-04 2022-12-02 上海朴颐化学科技有限公司 一种酶法制备α-酮戊二酸钙的方法
CN114105761B (zh) * 2021-11-19 2024-06-21 广东派特埃尔生物科技有限公司 一种α-酮戊二酸钠盐的合成工艺
CN115974679A (zh) * 2022-12-20 2023-04-18 绍兴市精益生物化工有限公司 α-酮戊二酸钙盐制备方法
CN119977789A (zh) * 2025-02-12 2025-05-13 江苏惠利生物科技有限公司 一种离子交换树脂制备高纯度α-酮戊二酸钙的方法

Family Cites Families (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2776926A (en) 1955-08-04 1957-01-08 Eugene S Sharpe Preparation of alpha-ketoglutaric acid by serratia marcescens
US2917528A (en) 1956-08-24 1959-12-15 Victor Chemical Works Alkanolaminealkanephosphonic acids and salts thereof
US2841616A (en) * 1956-10-30 1958-07-01 Campbell Soup Co Process for the recovery of alpha-ketoglutaric acid
US3875304A (en) 1970-04-24 1975-04-01 Schlitz Brewing Co J Livestock feed composition and method of preparing the same
US4045585A (en) 1976-05-19 1977-08-30 Decel Corporation Flavored animal food compositions
DE3151196A1 (de) * 1981-12-23 1983-06-30 Kurt Heinz Prof. Dr. 7800 Freiburg Bauer Verfahren zur herstellung von gut loeslichen 5-aminosalicylsaeure-arzneimittelzubereitungen
US6451341B1 (en) 1990-02-05 2002-09-17 Thomas J. Slaga Time release formulation of vitamins, minerals and other beneficial supplements
US5646187A (en) 1992-05-20 1997-07-08 Ab Erik Vinnars Use of alpha-ketoglutarate
US6306430B1 (en) 1998-04-16 2001-10-23 The Iams Company Process for decreasing adiposity using vitamin a as a dietary supplement
US6905707B2 (en) 1998-05-28 2005-06-14 Medical Research Institute Controlled release arginine alpha ketoglutarate
CO5140079A1 (es) 1998-10-14 2002-03-22 Novartis Ag Composicion farmaceutica de liberacion sostenida y metodo para liberar un agente farmaceuticamente activo de liberacion sostenida y metodo para liberar un agente far- maceuticamente activo
US6649654B1 (en) 1999-11-23 2003-11-18 The Regents Of The University Of California Methods for identifying and using IKK inhibitors
US7169755B2 (en) 2000-12-20 2007-01-30 Alcon, Inc. Solution for removing cataracts via liquefracture
US20060216358A1 (en) * 2003-05-07 2006-09-28 Christian Hansen Controlled release composition containing a strontium salt
JP4954867B2 (ja) * 2004-05-06 2012-06-20 オステオロジックス エイ/エス 有機金属塩類を製造するための高収率で迅速な合成法
PL368572A1 (en) 2004-06-17 2005-12-27 Sgp & Sons Ab Pharmaceutical compound for prevention and therapy of increased level of cholesterol, ldl and triglycerides as well as application of the pharmaceutical compound as an agent acting against atherosclerosis and used in circulatory system affections
US20090005437A1 (en) 2004-08-09 2009-01-01 Eyal Gottlieb Alpha-Ketoglutarates and Their Use as Therapeutic Agents
ES2510690T3 (es) 2004-12-17 2014-10-21 Alan B. Cash Método para extender la esperanza de vida y retrasar la aparición de enfermedad relacionada con la edad
US20060234250A1 (en) 2005-04-15 2006-10-19 Powers Ralph W Iii Methods of screening and compositions for life span modulators
WO2007001883A2 (en) 2005-06-20 2007-01-04 Accera, Inc. Method to reduce oxidative damage and improve mitochondrial efficiency
US20070105942A1 (en) 2005-11-08 2007-05-10 Heuer Marvin A Supplemental dietary composition for turning on anabolic switches in muscle, stimulating and/or optimizing protein synthesis, and/or potently signaling muscle building and/or growth via molecular pathways
US8367121B2 (en) 2005-11-23 2013-02-05 Florida A & M University Nutraceutical agent for attenuating the neurodegenerative process associated with Parkinson's disease
PL379512A1 (pl) 2006-04-21 2007-10-29 Sgp & Sons Ab Nowe metody i ich zastosowanie
PL226695B1 (pl) 2006-07-03 2017-08-31 Danuta Kruszewska Środek do zastosowania w zapobieganiu i/lub hamowaniu kolonizacji Helicobacter pylori, zastosowanie soli kwasu alfa‑ketoglutarowego z metalami alkalicznymi i ziem alkalicznych do wytwarzania środka leczniczego oraz dodatku do żywności do zapobiegania i/lub hamowania kolonizacji Helicobacter pylori
JP2010522190A (ja) 2007-03-19 2010-07-01 メタプロテオミクス, エルエルシー 骨及び関節の健康を助成するための方法と組成物
US20110039935A1 (en) 2007-07-02 2011-02-17 Entress Ab Use of pharmacologically active chemical compounds
EP2033623A1 (en) 2007-09-07 2009-03-11 Cutech S.R.L. Compositions comprising ornithine ketoglutarate (OKG)
JP5406643B2 (ja) 2008-09-22 2014-02-05 日本合成化学工業株式会社 α−オキソカルボン酸の金属塩の製造方法
CN101759553A (zh) 2008-11-21 2010-06-30 扬子江药业集团北京海燕药业有限公司 α-酮酸钙的制备方法
DE102009016119A1 (de) 2009-04-03 2010-10-14 Evonik Degussa Gmbh Nahrungsergänzungsmittel enthaltend alpha-Ketosäuren zur Unterstützung der Diabetestherapie
WO2010118419A2 (en) 2009-04-10 2010-10-14 Haiyan Qi Novel anti-aging agents and methods to identify them
CN102481269B (zh) 2009-05-11 2015-10-07 博格有限责任公司 包含辅酶q10的药物组合物及其制备方法
EP3120709A1 (en) 2009-05-28 2017-01-25 IAMS Europe B.V. Pet food in the form of a coated kibble
US9950019B2 (en) 2009-06-12 2018-04-24 Generex Pharmaceuticals, Inc. Compositions and methods for the prevention and treatment of brain diseases and conditions
PL2448577T3 (pl) 2009-06-30 2017-02-28 Derman Biomedicine Co. Ltd. Kompozycje zawierające berberynę lub jej analogi do leczenia trądziku różowatego lub chorób skóry związanych z zaczerwienieniem twarzy
WO2011060305A1 (en) 2009-11-12 2011-05-19 Nox Technologies, Inc. Potato skin compositions that lower cytosolic nadh level to mimic calorie restriction
WO2012114204A2 (en) 2011-02-15 2012-08-30 Ecole Polytechnique Federale De Lausanne (Epfl) Epfl-Tto Methods of treating mitochondrial dysfunction
JP2014512372A (ja) 2011-04-18 2014-05-22 ネステク ソシエテ アノニム α−HICA及びエイコサペンタエン酸を含有する栄養組成物
WO2012174537A2 (en) 2011-06-16 2012-12-20 President And Fellows Of Harvard College Small molecule screening for mouse satellite cell proliferation
CN102586347B (zh) * 2012-03-06 2014-04-09 江南大学 一种两阶段pH控制高产a-酮戊二酸的方法
US9532997B2 (en) 2012-04-03 2017-01-03 Whitehead Institute For Biomedical Research Compositions and methods for promoting intestinal stem cell function
ITBO20120226A1 (it) 2012-04-24 2013-10-25 Alfa Wassermann Spa Composizioni comprendenti ornitina alfa-chetoglutarato, processi per il loro ottenimento e il loro uso.
JP6029058B2 (ja) 2012-09-14 2016-11-24 国立研究開発法人農業・食品産業技術総合研究機構 シュウ酸カルシウムを含む氷核活性剤
PL3398594T3 (pl) 2012-09-19 2024-11-04 Grespo Ab Kompozycje do ulepszenia funkcji mózgu
CN102976927A (zh) 2012-12-26 2013-03-20 天津天成制药有限公司 α-酮戊二酸钙的制备方法
CA2896646A1 (en) 2012-12-27 2014-07-03 Hayashibara Co., Ltd. Skin-exterior anti-ageing composition and production method therefor
WO2014116985A1 (en) 2013-01-25 2014-07-31 Winning The Fight Inc. Composition for treatment of neurodegenerative disease
US9511057B2 (en) 2013-03-15 2016-12-06 The Board Of Trustees Of The Leland Stanford Junior University Methods for treating denervation-induced muscle atrophy
BR112015024186B1 (pt) 2013-03-19 2023-05-09 University Of South Florida Composições e métodos para produção de cetose de elevação e manutenção
US20160263092A1 (en) 2013-12-19 2016-09-15 Twi Biotechnology, Inc. Therapeutic uses of berberine formulations
CN113082009A (zh) 2014-02-12 2021-07-09 加利福尼亚大学董事会 用于治疗衰老和与年龄相关的疾病和症状的组合物和方法
WO2015171723A1 (en) 2014-05-06 2015-11-12 Research Development Foundation Methods for treating insulin resistance and for sensitizing patients to glp1 agonist therapy
KR102596106B1 (ko) 2014-06-30 2023-10-30 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 연령-관련 증상 및 질환의 치료를 위한 케토부티레이트 화합물 및 조성물
KR20250008786A (ko) 2014-07-29 2025-01-15 센젠 하이타이드 바이오파마슈티컬 리미티드 베르베린 염, 우르소데옥시콜산 염 및 병용물, 이들의 제조 및 응용 방법
WO2016019224A1 (en) 2014-07-31 2016-02-04 Indiana University Research And Technology Corporation Antithetical regulation of endothelial ace and ace2 by brg1-foxm1 complex underlies pathological cardiac hypertrophy
CN104529755B (zh) * 2014-12-29 2016-01-06 精晶药业股份有限公司 一种从转化液中分离α-酮戊二酸的方法
US20180050048A1 (en) 2015-04-06 2018-02-22 SHENZHEN HJGHTIDE-BIOPHARMAGEUTiCAL, LTD. Conjugate compounds of ursodeoxycholic, berberine or l-carnitine, and compositions and methods thereof
CN107849083A (zh) 2015-06-10 2018-03-27 益力舒健康公司 用于治疗皮肤病症的烟酰胺核苷和紫檀芪组合物和方法
WO2017008060A1 (en) 2015-07-08 2017-01-12 Unity Biotechnology, Inc. Compositions and methods for treating senescence-associated diseases and disorders
CN109803647A (zh) 2016-09-30 2019-05-24 加州大学董事会 α-丁酮酸、α-酮戊二酸和2-羟基丁酸用于刺激毛发生长
PL231635B1 (pl) 2017-01-03 2019-03-29 Politechnika Poznanska Sposób produkcji kwasu alfa-ketoglutarowego (AKG) z jednoskładnikowych roztworów wodnych
MX2017004010A (es) 2017-03-27 2018-02-09 Antonio Hernandez Miramontes Jorge Mezcla de oxalacetato, alfacetoglutarato, ácido tartánico y sales de lactato de calcio y sodio, para tratar pacientes con insuficiencia renal crónica.
CA3061381A1 (en) 2017-04-25 2018-11-01 Buck Institute For Research On Aging COMPOSITIONS COMPRISING α-KETOGLUTARATE FOR EXTENDING LIFESPAN AND HEALTHSPAN
WO2019038655A1 (en) 2017-08-21 2019-02-28 The Regents Of The University Of California COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES
CN112955139B (zh) 2018-09-25 2025-04-18 庞塞迪利昂健康特定活动公司 用于制备α-酮戊二酸钙的方法
US20210369750A1 (en) 2018-10-24 2021-12-02 Ponce De Leon Health Designated Activity Company Nicotinamide riboside compositions for healthspan extension
CN114126599A (zh) 2019-06-10 2022-03-01 巴克老龄化研究所 改变衰老相关分泌表型的方法和组合物
TWI869410B (zh) * 2019-06-10 2025-01-11 愛爾蘭商龐賽德萊昂健康公司 α-酮戊二酸鹽之持續釋放組合物
EP4175978A4 (en) 2020-07-02 2024-06-26 Ponce de Leon Health Designated Activity Company COMPOSITIONS AND METHODS FOR TREATING CRP-MEDIATED DISEASES
CN112941116B (zh) * 2021-01-04 2022-12-02 上海朴颐化学科技有限公司 一种酶法制备α-酮戊二酸钙的方法
CN115974679A (zh) * 2022-12-20 2023-04-18 绍兴市精益生物化工有限公司 α-酮戊二酸钙盐制备方法

Also Published As

Publication number Publication date
BR112021005668A2 (pt) 2021-06-22
PE20211816A1 (es) 2021-09-14
EP3856166A1 (en) 2021-08-04
JP7499259B2 (ja) 2024-06-13
JP2022502489A (ja) 2022-01-11
MX2021003482A (es) 2021-06-18
EP3856166A4 (en) 2022-06-22
KR20210065120A (ko) 2021-06-03
CO2021004529A2 (es) 2021-04-30
US11802103B2 (en) 2023-10-31
KR102833111B1 (ko) 2025-07-10
IL281761B1 (en) 2025-05-01
TW202024013A (zh) 2020-07-01
AU2019350699B2 (en) 2024-05-23
CN112955139B (zh) 2025-04-18
US20210371368A1 (en) 2021-12-02
IL281761B2 (en) 2025-09-01
SG11202102204PA (en) 2021-04-29
PH12021550403A1 (en) 2021-10-04
CL2021000728A1 (es) 2021-10-22
IL281761A (en) 2021-05-31
TWI863930B (zh) 2024-12-01
CA3112205A1 (en) 2020-04-02
WO2020068705A1 (en) 2020-04-02
CN112955139A (zh) 2021-06-11
AU2019350699A1 (en) 2021-04-08

Similar Documents

Publication Publication Date Title
PH12021550403A1 (en) Process of making calcium alpha-ketoglutarate
ZA202001717B (en) Compounds, salts thereof and methods for treatment of diseases
MX2018010427A (es) Formas solidas de un inhibidor de tienopirimidindiona acetil coa carboxilasa y metodos para su produccion.
MX2017016900A (es) Método y aparato para el soporte extracorpóreo del feto prematuro.
EP4351045A3 (en) Methods and apparatus for setting subband csi-related parameters
SG10201807693YA (en) Methods for recombinant production of saffron compounds
NZ796822A (en) Cancer treatment
MX2020009231A (es) Materiales biofabricados con forma tridimensional y metodos de fabricacion.
MX2017008280A (es) Proceso para elaborar cenicriviroc y analogos relacionados.
PH12021551212A1 (en) Process for preparation of anthranilamides
MX2022001703A (es) Metodos para producir estiercol tratado.
WO2019109067A3 (en) Creatine prodrugs, compositions and methods of use thereof
CL2021000663A1 (es) Proceso para la producción de gas de síntesis.
MX2020006070A (es) Proceso de producción de n-acetil taurinato de magnesio.
IL279168B (en) A process for the preparation of eribulin
MX2019004182A (es) Proceso para la fabricacion de 2,6-dimetil-5-hepten-1-al.
GB201814291D0 (en) Process for the production of gallium radionculides
MY175821A (en) Microorganism having ability to produce o-succinylhomoserine or succinic acid, and method for producing succinic acid or o-succinylhomoserine by using same
MX386696B (es) Proceso para producir analogos de anillo de arilomicina
ZA202408113B (en) Improved process for the manufacture of osimertinib
PH12020550958A1 (en) Method for producing carbodiimides
MY207512A (en) Process for manufacturing alkanesulfonic acids
WO2019094584A3 (en) Method for producing phosphorus chemicals from wet process phosphate
MY209549A (en) Process for the preparation of diosmin
AU2019248350A8 (en) Process for making sarecycline hydrochloride